Mario R Romano1, Ugo Cipollone2, Francesco Semeraro3, Michele Rinaldi4, Ciro Costagliola11Dipartimento di Scienze per la Salute, Università degli Studi del Molise, Campobasso; 2Dipartimento di Oftalmologia, Ospedale G Vietri, Larino ...
Mario R Romano +3 more
doaj
Management of polypoidal choroidal vasculopathy: Malaysian Consensus Guideline 2023. [PDF]
Ngah NF +14 more
europepmc +1 more source
Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg. [PDF]
Sherif MZ +6 more
europepmc +1 more source
Severe Polypoidal Choroidal Vasculopathy as a Harbinger of Spontaneous Suprachoroidal Hemorrhage. [PDF]
Tao BK +7 more
europepmc +1 more source
Long-Term Management of Polypoidal Choroidal Vasculopathy: A Narrative Review. [PDF]
Koh A +6 more
europepmc +1 more source
Correction: Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source
Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. [PDF]
Giridhar A, Lekha T, Chandran K.
europepmc +1 more source
Assessing Polypoidal Choroidal Vasculopathy-Related OCT Features in the TENAYA and LUCERNE Trials. [PDF]
Teo KYC +7 more
europepmc +1 more source
Peripheral polypoidal choroidal vasculopathy
Tingkun Shi, Haoyu Chen
doaj +1 more source
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source

